Debruyne FM - Search Results

1

Use of maintenance intravesical bacillus Calmette-Guérin (BCG), with or without intradermal BCG, in patients with recurrent superficial bladder cancer. Long-term follow-up of a randomized phase 2 study.

Witjes JA, Fransen MP, van der Meijden AP, Doesburg WH, Debruyne FM. Witjes JA, et al. Among authors: debruyne fm. Urol Int. 1993;51(2):67-72. doi: 10.1159/000282516. Urol Int. 1993. PMID: 8351757 Clinical Trial.

2

Intravesical chemotherapy for superficial bladder cancer.

Witjes JA, Debruyne FM. Witjes JA, et al. Among authors: debruyne fm. Nat Clin Pract Urol. 2004 Dec;1(2):56-7. doi: 10.1038/ncpuro0009. Nat Clin Pract Urol. 2004. PMID: 16474497 No abstract available.

3

Presence of interleukin-2 in urine of superficial bladder cancer patients after intravesical treatment with bacillus Calmette-Guérin.

De Jong WH, De Boer EC, Van der Meijden AP, Vegt P, Steerenberg PA, Debruyne FM, Ruitenberg EJ. De Jong WH, et al. Among authors: debruyne fm. Cancer Immunol Immunother. 1990;31(3):182-6. doi: 10.1007/BF01744734. Cancer Immunol Immunother. 1990. PMID: 2337907 Free PMC article.

4

BCG-(RIVM) versus mitomycin intravesical therapy in patients with superficial bladder cancer. EORTC GU Group and the Dutch South-East Collaborative Group.

Debruyne FM, van der Meijden AP, Franssen MP. Debruyne FM, et al. Prog Clin Biol Res. 1989;303:435-46. Prog Clin Biol Res. 1989. PMID: 2506556 Clinical Trial. No abstract available.

5

Ultrasonic determination of the residual bladder volume.

Hendrikx AJ, Doesburg WH, van den Stappen W, Hofmans PA, Debruyne FM. Hendrikx AJ, et al. Among authors: debruyne fm. Urol Int. 1989;44(2):96-102. doi: 10.1159/000281479. Urol Int. 1989. PMID: 2658241

6

Aspects of non-specific immunotherapy with BCG in superficial bladder cancer: an overview.

van der Meijden AP, Debruyne FM, Steerenberg PA, de Jong WH. van der Meijden AP, et al. Among authors: debruyne fm. Prog Clin Biol Res. 1989;310:11-33. Prog Clin Biol Res. 1989. PMID: 2672011 Review. No abstract available.

7

Intravesical BCG administration in the guinea pig. Histomorphological aspects.

van der Meijden AP, de Jong WH, Steerenberg PA, Debruyne FM, Ruitenberg JE. van der Meijden AP, et al. Among authors: debruyne fm. Prog Clin Biol Res. 1989;310:67-79. Prog Clin Biol Res. 1989. PMID: 2672024 No abstract available.

8

Bladder carcinoma in patients less than 40 years of age.

Witjes JA, Debruyne FM. Witjes JA, et al. Among authors: debruyne fm. Urol Int. 1989;44(2):81-3. doi: 10.1159/000281475. Urol Int. 1989. PMID: 2728130

9

Intravesical BCG administration in the guinea pig. A histomorphological study.

van der Meijden AP, de Jong WH, Steerenberg PA, Walvoort HC, de Boer EC, Debruyne FM, Ruitenberg EJ. van der Meijden AP, et al. Among authors: debruyne fm. Virchows Arch B Cell Pathol Incl Mol Pathol. 1988;55(4):207-15. doi: 10.1007/BF02896577. Virchows Arch B Cell Pathol Incl Mol Pathol. 1988. PMID: 2900573

10

Immunological aspects of intravesical administration of Bacillus Calmette-Guérin (BCG) in the guinea pig.

van der Meijden AP, de Jong WH, de Boer EC, Steerenberg PA, Debruyne FM, Ruitenberg EJ. van der Meijden AP, et al. Among authors: debruyne fm. Urol Res. 1989;17(1):47-55. doi: 10.1007/BF00261051. Urol Res. 1989. PMID: 2922891

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

667 results

Search Page